Destiny of HER2/neu in the era of HER2-low in 2024

Dr. Shabnam Jaffer, MD, Professor of Pathology, Zucker School of Medicine at Hofstra University/ Northwell Health, USA, discusses " Destiny of HER2/neu in the era of HER2-low in 2024"